HAWAII SENATE ASPARTAME BILL WILL BE HEARD MONDAY


Dr. Betty Martini, D.Hum.
Mission Possible World Health International
9270 River Club Parkway
Duluth, Georgia 30097
Telephone: 770-242-2599
E-Mail: BettyM19@mindspring.com



Posted: 25 February 2008


I'm pleased to announce that Senator David Y. Ige, Chairman of Senate Health Committee, has scheduled the Senate bill to ban aspartame. It will be heard Monday, February 25th. For those who can testify it will be heard in Room 16 at 1:15 P.M. According to Jade Bruhjell who has been behind getting these bills introduced they are very interested in those who appear but written testimony can be emailed to testimony@capital.hawaii.gov Senator Ige's office number is 808-586-6230 if you wish to check for further details.

The Hawaii HOUSE Health bill to ban aspartame was deferred: http://www.mpwhi.com/hhhb_2680_political_paralysis.htm This is an entirely different bill still giving us the ability to get this neurotoxin removed from the public food supply.

Aspartame can precipitate diabetes, interacts with insulin, can mimic and precipitate MS, trigger psychiatric and behavioral problems, trigger lupus and male sexual dysfunction, cause brain tumors and other cancers, birth defects, mental retardation, interacts with drugs and vaccines and a list of other horrors discussed in the medical texts, Aspartame Disease: An Ignored Epidemic by H. J. Roberts, M.D., http://www.sunsentpress.com and Excitotoxins: The Taste That Kills by neurosurgeon Russell Blaylock, M.D., http://www.russellblaylockmd.com The Senate Health Committee will be given DVDs of 'Sweet Misery: A Poisoned World' http://www.soundandfury.tv so they can hear the testimony of world experts. (I highly recommend this extraordinary documentary - Jeff)

Aspartame remains illegal because its adulterated and violates the Delaney Amendment which forbids adding anything that can cause cancer. Two prestigious studies by the Ramazzini Institute released in 2005 and 2007, peer reviewed by 7 world experts, have proven beyond any shadow of a doubt aspartame is a multipotential carcinogen even in small amounts and can be passed on to the offspring. Brain tumors were noted in original studies and FDA toxicologist Dr. Adrian Gross told Congress that not only does aspartame violate the Delaney Amendment but FDA should not have been able to set an allowable dose. Aspartame also violates Interstate Commerce laws because you can't ship an adulterated product for sale.

I want to thank all those who called to ask that this bill be scheduled to be heard in these last minutes, even from other countries, and especially the tireless efforts of Stephen Fox (Mission Possible New Mexico).

Below are members of the Senate House Committee and their information, as well as the bill to ban aspartame (NutraSweet/Equal, etc.) from the beautiful Hawaiian Islands, our 50th State.

Dr. Betty Martini, D.Hum.
Founder, Mission Possible World Health International
9270 River Club Parkway
Duluth, Georgia 30097
770-242-2599
E-Mail: BettyM19@mindspring.com
http://www.wpwhi.com
http://www.whno.net
http://www.dorway.com

Aspartame Toxicity Center: http://www.holisticmed.com/aspartame


______________________________

David Y. Ige Chairman of Senate Health Committee
16th Senatorial District
Hawaii State Capitol, Room 215
415 South Beretania Street
Honolulu, HI 96813
Phone 808-586-6230; fax 808-586-6231
E-Mail: sendige@Capitol.hawaii.gov

______________________________

Carol Fukunaga, Senator, Vice Chair
11th Senatorial District
Hawaii State Capitol, Room 216
415 South Beretania Street
Honolulu, HI 96813
Phone 808-586-6890; fax 808-586-6899
E-Mail: senfukunaga@Capitol.hawaii.gov Rosalyn H. Baker
5th Senatorial District
Hawaii State Capitol, Room 210
415 South Beretania Street
Honolulu, HI 96813
Phone 808-586-6070; fax 808-586-6071
From Maui, toll free 984-2400 + 66070
E-Mail: senbaker@Capitol.hawaii.gov

______________________________

Ron Menor
17th Senatorial District
Hawaii State Capitol, Room 208
415 South Beretania Street
Honolulu, HI 96813
Phone 808-586-6740; fax 808-586-6829
E-Mail: senmenor@Capitol.hawaii.gov

______________________________

Paul Whalen
3rd Senatorial District
Hawaii State Capitol, Room 223
415 South Beretania Street
Honolulu, HI 96813
Phone 808-586-9385; fax 808-586-9391
From the Big Island, toll free 974-4000 + 69385
E-Mail: senwhalen@Capitol.hawaii.gov


Report Title:
Artificial Sweetener; Aspartame; Ban; Food

Description:
Bans the use of the artificial sweetener aspartame in food products.


THE SENATE
S.B. NO.2506
TWENTY-FOURTH LEGISLATURE, 2008

STATE OF HAWAII

A BILL FOR AN ACT

relating to food.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

SECTION 1. The legislature finds it is imperative for the public health, safety and welfare to declare that aspartame and its derivative compounds, in all of their trade names, are poisonous and deleterious food additives due to their neurotoxic and carcinogenic metabolites.
The legislature finds that federal authorities have not intended to or expressed an intention to occupy and preempt areas of concern regarding the prohibition of toxic, neurotoxic, carcinogenic, poisonous or deleterious food additives, and therefore the legislature may prohibit the sale of products containing aspartame and its derivative compounds in order to protect and ensure the public health, safety and welfare.
SECTION 2. Section 328-1, Hawaii Revised Statutes, is amended by adding a new definition to be appropriately inserted and to read as follows: ""Aspartame" means the artificial sweetener with the technical name L-aspartyl-L-phenylalanine methyl ester."
SECTION 3. Section 328-6, Hawaii Revised Statutes, is amended to read as follows:
"'328-6 Prohibited acts. The following acts and the causing thereof within the State by any person are prohibited:
(1) The manufacture, sale, delivery, holding, or offering for sale of any food, drug, device, or cosmetic that is adulterated or misbranded;
(2) The adulteration or misbranding of any food, drug, device, or cosmetic;
(3) The receipt in commerce of any food, drug, device, or cosmetic that is adulterated or misbranded, and the delivery or proffered delivery thereof for pay or otherwise;
(4) The sale, delivery for sale, holding for sale, or offering for sale of any article in violation of section 328-11, 328-12, or 328-17;
(5) The dissemination of any false advertisement;
(6) The refusal to permit entry or inspection, or to permit the taking of a sample, as authorized by sections 328-22 and 328-23 to 328-27, or to permit access to or copying of any record as authorized by section 328-23;
(7) The giving of a guaranty or undertaking which guaranty or undertaking is false, except by a person who relied on a guaranty or undertaking to the same effect signed by, and containing the name and address of the person residing in the State from whom the person received in good faith the food, drug, device, or cosmetic;
(8) The removal or disposal of a detained or embargoed article in violation of sections 328-25 to 328-27;
(9) The alteration, mutilation, destruction, obliteration, or removal of the whole or any part of the labeling of, or the doing of any other act with respect to a food, drug, device, or cosmetic, if the act is done while the article is held for sale and results in the article being adulterated or misbranded;
(10) Forging, counterfeiting, simulating, or falsely representing, or without proper authority using any mark, stamp, tag, label, or other identification device authorized or required by rules adopted under this part or regulations adopted under the Federal Act;
(11) The use, on the labeling of any drug or in any advertisement relating to the drug, of any representation or suggestion that an application with respect to the drug is effective under section 328-17, or that the drug complies with that section;
(12) The use by any person to the person's own advantage, or revealing other than to the department of health or to the courts when relevant in any judicial proceeding under this part, any information acquired under authority of section 328-11, 328-12, 328-17, or 328-23, concerning any method or process which as a trade secret is entitled to protection;
(13) In the case of a prescription drug distributed or offered for sale in this State, the failure of the manufacturer, packer, or distributor thereof to maintain for transmittal, or to transmit, to any practitioner who makes written request for information as to the drug, true and correct copies of all printed matter which is required to be included in any package in which that drug is distributed or sold, or such other printed matter as is approved under the Federal Act. Nothing in this paragraph shall be construed to exempt any person from any labeling requirement imposed by or under other provisions of this part;
(14) (A) Placing or causing to be placed upon any drug or device or container thereof, with intent to defraud, the trade name or other identifying mark, or imprint of another or any likeness of any of the foregoing; or
(B) Selling, dispensing, disposing of, or causing to be sold, dispensed, or disposed of, or concealing or keeping in possession, control, or custody, with intent to sell, dispense, or dispose of, any drug, device, or any container thereof, with knowledge that the trade name or other identifying mark or imprint of another or any likeness of any of the foregoing has been placed thereon in a manner prohibited by subparagraph (A); or
(C) Making, selling, disposing of, or causing to be made, sold, or disposed of, or keeping in possession, control, or custody, or concealing, with intent to defraud, any punch, die, plate, or other thing designed to print, imprint, or reproduce that trade name or other identifying mark or imprint of another or any likeness of any of the foregoing upon any drug, device, or container thereof;
(15) Except as provided in part VI and section 461-1, dispensing or causing to be dispensed a different drug or brand of drug in place of the drug or brand of drug ordered or prescribed without express permission in each case of the person ordering or prescribing;
(16) The distribution in commerce of a consumer commodity as defined in this part, if such commodity is contained in a package, or if there is affixed to that commodity a label, which does not conform to this part and of rules adopted under authority of this part; provided that this prohibition shall not apply to persons engaged in business as wholesale or retail distributors of consumer commodities except to the extent that such persons:
(A) Are engaged in the packaging or labeling of such commodities; or
(B) Prescribe or specify by any means the manner in which such commodities are packaged or labeled;
(17) The selling or dispensing in restaurants, soda fountains, drive-ins, lunch wagons, or similar public eating establishments of imitation milk and imitation milk products in place of fresh milk and fresh milk products respectively; of liquid or dry products which simulate cream but do not comply with content requirements for cream in place of cream; of non-dairy frozen desserts which do not comply with content requirements for dairy frozen desserts in place of dairy frozen desserts; and of any other imitation food or one made in semblance of a genuine food in place of such genuine food, unless the consumer is notified by either proper labeling or conspicuous posted signs or conspicuous notices on menu cards and advertisements informing of such substitution, to include but not limited to the substitution of imitation milk in milk shake and malted milk drinks;
(18) Wilfully and falsely representing or using any devices, substances, methods, or treatment as effective in the diagnosis, cure, mitigation, treatment, or alleviation of cancer. This paragraph shall not apply to any person who depends exclusively upon prayer for healing in accordance with teachings of a bona fide religious sect, denomination, or organization, nor to a person who practices such teachings;
(19) The selling or offering for sale at any food facility which serves or sells over the counter directly to the consumer an unlabeled or unpackaged food that is a confectionery which contains alcohol in excess of one-half of one per cent by weight unless the consumer is notified of that fact by either proper labeling or conspicuous posted signs or conspicuous notices on menu cards and advertisements;
(20) The sale to a person below the age of twenty-one years of any food which is a confectionery which contains alcohol in excess of one-half of one per cent by weight[.];
(21) After December 31, 2008, the manufacture, sale or delivery or holding or offering for sale of any food containing any amount of aspartame and its derivative compounds in any of their trade names."
SECTION 4. This section shall not apply to the sale, delivery, holding, or offering for sale of any food product containing aspartame prior to January 1, 2009.
SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 6. This Act shall take effect upon its approval.